Universidade Federal de São Paulo, São Paulo, SP, Brazil.
Rev Paul Pediatr. 2021 Jan 11;39:e2019275. doi: 10.1590/1984-0462/2021/39/2019275. eCollection 2021.
Acute respiratory distress syndrome (ARDS) can be a devastating condition in children with cancer and alveolar recruitment maneuvers (ARMs) can theoretically improve oxygenation and survival. The study aimed to assess the feasibility of ARMs in critically ill children with cancer and ARDS.
We retrospectively analyzed 31 maneuvers in a series of 12 patients (median age of 8.9 years) with solid tumors (n=4), lymphomas (n=2), acute lymphoblastic leukemia (n=2), and acute myeloid leukemia (n=4). Patients received positive end-expiratory pressure from 25 up to 40 cmH20, with a delta pressure of 15 cmH2O for 60 seconds. We assessed blood gases pre- and post-maneuvers, as well as ventilation parameters, vital signs, hemoglobin, clinical signs of pulmonary bleeding, and radiological signs of barotrauma. Pre- and post-values were compared by the Wilcoxon test.
Median platelet count was 53,200/mm3. Post-maneuvers, mean arterial pressure decreased more than 20% in two patients, and four needed an increase in vasoactive drugs. Hemoglobin levels remained stable 24 hours after ARMs, and signs of pneumothorax, pneumomediastinum, or subcutaneous emphysema were absent. Fraction of inspired oxygen decreased significantly after ARMs (FiO2; p=0.003). Oxygen partial pressure (PaO2)/FiO2 ratio increased significantly (p=0.0002), and the oxygenation index was reduced (p=0.01), but all these improvements were transient. Recruited patients' 28-day mortality was 58%.
ARMs, although feasible in the context of thrombocytopenia, lead only to transient improvements, and can cause significant hemodynamic instability.
急性呼吸窘迫综合征(ARDS)可导致癌症患儿病情恶化,肺泡复张手法(ARMs)理论上可改善氧合和存活率。本研究旨在评估 ARMs 对癌症合并 ARDS 危重症患儿的可行性。
我们对 12 例患者(中位年龄 8.9 岁)的 31 次 ARMs 进行了回顾性分析,其中 4 例为实体瘤,2 例为淋巴瘤,2 例为急性淋巴细胞白血病,4 例为急性髓系白血病。患者接受 25 至 40 cmH20 的呼气末正压,delta 压力为 15 cmH2O,持续 60 秒。我们评估了操作前后的血气、通气参数、生命体征、血红蛋白、肺出血的临床征象和气压伤的影像学征象。采用 Wilcoxon 检验比较了前后值。
中位血小板计数为 53200/mm3。在两名患者中,操作后平均动脉压下降超过 20%,四名患者需要增加血管活性药物。操作后 24 小时血红蛋白水平保持稳定,未见气胸、纵隔气肿或皮下气肿的迹象。ARMs 后吸入氧分数(FiO2)显著下降(p=0.003)。氧分压(PaO2)/FiO2 比值显著增加(p=0.0002),氧合指数降低(p=0.01),但所有这些改善均为一过性。接受 ARMs 治疗的患者 28 天死亡率为 58%。
尽管 ARMs 在血小板减少的情况下是可行的,但只能导致短暂的改善,并可能导致显著的血流动力学不稳定。